SCLN Financial Facts

Total operating expenses: 31.92M
Product sales: 31.93M
See Full Income Statement

Total assets: 180.23M
Prepaid expenses and other current assets: 2.29M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -27.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -2.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
4/1/13 Q413 $0.04$0.12 -$0.08$33.1M$35.3M = -1.7% Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M = -3.4% Details
11/12/13 Q313 $0.18$0.15 +$0.03$35.2M$39.7M = +1.6% Details
8/7/13 Q213 $0.09$0.11 -$0.02$29.81M$33.3M = -25.9% Details
11/9/12 Q312 $0.20$0.21 -$0.01$40.7M$44.8M -13.9% Details
8/8/12 Q212 $0.19$0.17 +$0.02$40.3M$41.98M -11% Details
5/9/12 Q112 $0.15$0.14 +$0.01$39.2M$37.08M N/A -22.8% Details
3/13/12 Q411 $0.20$0.12 +$0.08$41.4M$40.39M -13% Details